Search

Bester, Assaf C, Jonathan D Lee, Alejandro Chavez, Yu-Ru Lee, Daphna Nachmani, Suhani Vora, Joshua Victor, et al. 2018. “An Integrated Genome-Wide CRISPRa Approach to Functionalize LncRNAs in Drug Resistance.”. Cell 173 (3): 649-664.e20.

Patnaik, Akash, Kenneth D Swanson, Eva Csizmadia, Aniruddh Solanki, Natalie Landon-Brace, Marina P Gehring, Katja Helenius, et al. 2017. “Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.”. Cancer Discovery 7 (7): 750-65.

van de Ven, Anne L, Shifalika Tangutoori, Paige Baldwin, Ju Qiao, Codi Gharagouzloo, Nina Seitzer, John G Clohessy, et al. 2017. “Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53-Deficient Prostate Cancer to Radiation.”. Molecular Cancer Therapeutics 16 (7): 1279-89.

Matsumoto, Akinobu, John G Clohessy, and Pier Paolo Pandolfi. 2017. “SPAR, a LncRNA Encoded MTORC1 Inhibitor.”. Cell Cycle (Georgetown, Tex.) 16 (9): 815-16.

Pasut, Alessandra, Akinobu Matsumoto, John G Clohessy, and Pier Paolo Pandolfi. 2016. “The Pleiotropic Role of Non-Coding Genes in Development and Cancer.”. Current Opinion in Cell Biology 43: 104-13.

Rau, Rachel, Daniel Magoon, Sarah Greenblatt, Li Li, Colleen Annesley, Amy S Duffield, David Huso, et al. 2014. “NPMc+ Cooperates With Flt3/ITD Mutations to Cause Acute Leukemia Recapitulating Human Disease.”. Experimental Hematology 42 (2): 101-13.e5.

Fagoonee, Sharmila, Claudia Bearzi, Ferdinando Di Cunto, John G Clohessy, Roberto Rizzi, Markus Reschke, Emanuela Tolosano, et al. 2013. “The RNA Binding Protein ESRP1 Fine-Tunes the Expression of Pluripotency-Related Factors in Mouse Embryonic Stem Cells.”. PloS One 8 (8): e72300.

Alimonti, Andrea, Arkaitz Carracedo, John G Clohessy, Lloyd C Trotman, Caterina Nardella, Ainara Egia, Leonardo Salmena, et al. 2010. “Subtle Variations in Pten Dose Determine Cancer Susceptibility.”. Nature Genetics 42 (5): 454-8.

Montanaro, L, M Brigotti, J Clohessy, S Barbieri, C Ceccarelli, D Santini, M Taffurelli, et al. 2006. “Dyskerin Expression Influences the Level of Ribosomal RNA Pseudo-Uridylation and Telomerase RNA Component in Human Breast Cancer.”. The Journal of Pathology 210 (1): 10-8.

Inoue, Kosuke, Dhruv S Kazi, Muthiah Vaduganathan, and Rishi K Wadhera. 2025. “Prescription Patterns for GLP-1 Receptor Agonists and SGLT2 Inhibitors by Physicians’ Years in Practice”. Journal of General Internal Medicine.